How much is the India Pharmaceuticals Industry market?

The India Pharmaceuticals Industry market size was valued at USD 55.97 Billion in 2023. Read More

What is the growth rate of the India Pharmaceuticals Industry market?

Throughout the predicted period of 2023–2032, the market is expected to develop at a CAGR of 8.80%. Read More

Who are the key players in the India Pharmaceuticals Industry market?

The key players in the market are GlaxoSmithKline plc6., Biocon Limited6., Pfizer Inc6., Novartis AG6., Merck & Co., Inc., Torrent Pharma., Divi's Laboratories, Aurobindo Pharma Limited, Mankind Pharma, Abbott. Read More

Which Therapeutic Category led the India Pharmaceuticals Industry market?

The Cardiovascular category dominated the market in 2022. Read More

Which kind of medication held the biggest market share in India's pharmaceutical sector?

The OTC Drugs had the largest share in the market. Read More

India Pharmaceuticals Industry

ID: MRFR/HC/20205-HCR

128 Pages

Rahul Gotadki

Last Updated: April 22, 2026

India Pharmaceuticals Industry Market Research Report: Size, Share, Trend Analysis By Therapeutic Category (Anti-Infectives, Cardiovascular, Gastrointestinal, Anti Diabetic, Respiratory, Dermatological, Musculo-Skeletal System, Nervous System, Others), By Drug Type (Prescription Drug, OTC Drugs) - Growth Outlook & Industry Forecast 2025 To 2035

India Pharmaceuticals Industry Infographic

Summary Table of Contents Segmentation Download PDF

1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
1. 2.1 Definition
2. 2.2 Scope of the Study
  1. 2.2.1 Research Objective
  2. 2.2.2 Assumptions
  3. 2.2.3 Limitations
3 RESEARCH METHODOLOGY
1. 3.1 Overview
2. 3.2 Data Mining
3. 3.3 Secondary Research
4. 3.4 Primary Research
  1. 3.4.1 Primary Interviews and Information Gathering Process
  2. 3.4.2 Breakdown of Primary Respondents
5. 3.5 Forecasting Model
6. 3.6 Market Size Estimation
  1. 3.6.1 Bottom-Up Approach
  2. 3.6.2 Top-Down Approach
7. 3.7 Data Triangulation
8. 3.8 Validation
4 MARKET DYNAMICS
1. 4.1 Overview
2. 4.2 Drivers
3. 4.3 Restraints
4. 4.4 Opportunities
5 MARKET FACTOR ANALYSIS
1. 5.1 Value Chain Analysis
2. 5.2 Porter’s Five Forces Analysis
  1. 5.2.1 Bargaining Power of Suppliers
  2. 5.2.2 Bargaining Power of Buyers
  3. 5.2.3 Threat of New Entrants
  4. 5.2.4 Threat of Substitutes
  5. 5.2.5 Intensity of Rivalry
3. 5.3 COVID-19 Impact Analysis
  1. 5.3.1 Market Impact Analysis
  2. 5.3.2 Regional Impact
  3. 5.3.3 Opportunity and Threat Analysis
6 India Pharmaceuticals Industry , BY THERAPEUTIC CATEGORY
1. 6.1 Overview
2. 6.2 Anti-Infectives
3. 6.3 Cardiovascular
4. 6.4 Gastrointestinal
5. 6.5 Anti Diabetic
6. 6.6 Respiratory
7. 6.7 Dermatological
8. 6.8 Musculo-Skeletal System
9. 6.9 Nervous System
10. 6.10 Others
7 India Pharmaceuticals Industry , BY DRUG TYPE
1. 7.1 Overview
2. 7.2 Prescription Drug
3. 7.3 OTC Drugs
8 COMPETITIVE LANDSCAPE
1. 8.1 Overview
2. 8.2 Competitive Analysis
3. 8.3 Market Share Analysis
4. 8.4 Major Growth Strategy in the India Pharmaceuticals Industry Market,
5. 8.5 Competitive Benchmarking
6. 8.6 Leading Players in Terms of Number of Developments in the India Pharmaceuticals Industry Market,
7. 8.7 Key developments and Growth Strategies
  1. 8.7.1 New Product Launch/Service Deployment
  2. 8.7.2 Merger & Acquisitions
  3. 8.7.3 Joint Ventures
8. 8.8 Major Players Financial Matrix
  1. 8.8.1 Sales & Operating Income, 2022
  2. 8.8.2 Major Players R&D Expenditure. 2022
9 COMPANY PROFILES
1. 9.1 Cipla Inc.
  1. 9.1.1 Company Overview
  2. 9.1.2 Financial Overview
  3. 9.1.3 Products Offered
  4. 9.1.4 Key Developments
  5. 9.1.5 SWOT Analysis
  6. 9.1.6 Key Strategies
2. 9.2 DR. REDDY’S LABORATORIES LTD.
  1. 9.2.1 Company Overview
  2. 9.2.2 Financial Overview
  3. 9.2.3 Products Offered
  4. 9.2.4 Key Developments
  5. 9.2.5 SWOT Analysis
  6. 9.2.6 Key Strategies
3. 9.3 Lupin LIMITED.
  1. 9.3.1 Company Overview
  2. 9.3.2 Financial Overview
  3. 9.3.3 Products Offered
  4. 9.3.4 Key Developments
  5. 9.3.5 SWOT Analysis
  6. 9.3.6 Key Strategies
4. 9.4 UN PHARMACEUTICAL INDUSTRIES LTD.
  1. 9.4.1 Company Overview
  2. 9.4.2 Financial Overview
  3. 9.4.3 Products Offered
  4. 9.4.4 Key Developments
  5. 9.4.5 SWOT Analysis
  6. 9.4.6 Key Strategies
5. 9.5 Cadila Pharmaceuticals.
  1. 9.5.1 Company Overview
  2. 9.5.2 Financial Overview
  3. 9.5.3 Products Offered
  4. 9.5.4 Key Developments
  5. 9.5.5 SWOT Analysis
  6. 9.5.6 Key Strategies
6. 9.6 GlaxoSmithKline plc.
  1. 9.6.1 Company Overview
  2. 9.6.2 Financial Overview
  3. 9.6.3 Products Offered
  4. 9.6.4 Key Developments
  5. 9.6.5 SWOT Analysis
  6. 9.6.6 Key Strategies
7. 9.7 BIOCON LIMITED.
  1. 9.7.1 Company Overview
  2. 9.7.2 Financial Overview
  3. 9.7.3 Products Offered
  4. 9.7.4 Key Developments
  5. 9.7.5 SWOT Analysis
  6. 9.7.6 Key Strategies
8. 9.8 PFIZER INC.
  1. 9.8.1 Company Overview
  2. 9.8.2 Financial Overview
  3. 9.8.3 Products Offered
  4. 9.8.4 Key Developments
  5. 9.8.5 SWOT Analysis
  6. 9.8.6 Key Strategies
9. 9.9 Novartis AG.
  1. 9.9.1 Company Overview
  2. 9.9.2 Financial Overview
  3. 9.9.3 Products Offered
  4. 9.9.4 Key Developments
  5. 9.9.5 SWOT Analysis
  6. 9.9.6 Key Strategies
10. 9.10 Merck & Co., Inc.
  1. 9.10.1 Company Overview
  2. 9.10.2 Financial Overview
  3. 9.10.3 Products Offered
  4. 9.10.4 Key Developments
  5. 9.10.5 SWOT Analysis
  6. 9.10.6 Key Strategies
11. 9.11 Torrent Pharma.
  1. 9.11.1 Company Overview
  2. 9.11.2 Financial Overview
  3. 9.11.3 Products Offered
  4. 9.11.4 Key Developments
  5. 9.11.5 SWOT Analysis
  6. 9.11.6 Key Strategies
12. 9.12 Divi's Laboratories
  1. 9.12.1 Company Overview
  2. 9.12.2 Financial Overview
  3. 9.12.3 Products Offered
  4. 9.12.4 Key Developments
  5. 9.12.5 SWOT Analysis
  6. 9.12.6 Key Strategies
13. 9.13 Aurobindo Pharma Limited
  1. 9.13.1 Company Overview
  2. 9.13.2 Financial Overview
  3. 9.13.3 Products Offered
  4. 9.13.4 Key Developments
  5. 9.13.5 SWOT Analysis
  6. 9.13.6 Key Strategies
14. 9.14 Mankind Pharma
  1. 9.14.1 Company Overview
  2. 9.14.2 Financial Overview
  3. 9.14.3 Products Offered
  4. 9.14.4 Key Developments
  5. 9.14.5 SWOT Analysis
  6. 9.14.6 Key Strategies
15. 9.15 Abbott
  1. 9.15.1 Company Overview
  2. 9.15.2 Financial Overview
  3. 9.15.3 Products Offered
  4. 9.15.4 Key Developments
  5. 9.15.5 SWOT Analysis
  6. 9.15.6 Key Strategies
10 APPENDIX
1. 10.1 References
2. 10.2 Related Reports LIST OF TABLES
TABLE 1 INDIA PHARMACEUTICALS INDUSTRY MARKET, SYNOPSIS, 2018-2032
TABLE 2 INDIA PHARMACEUTICALS INDUSTRY MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION) India Pharmaceuticals Industry , BY THERAPEUTIC CATEGORY, 2018-2032 (USD BILLION) India Pharmaceuticals Industry , BY DRUG TYPE, 2018-2032 (USD BILLION) LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE INDIA PHARMACEUTICALS INDUSTRY MARKET
FIGURE 3 MARKET DYNAMICS FOR THE INDIA PHARMACEUTICALS INDUSTRY MARKET
FIGURE 4 INDIA PHARMACEUTICALS INDUSTRY MARKET, SHARE (%), BY THERAPEUTIC CATEGORY, 2022
FIGURE 5 INDIA PHARMACEUTICALS INDUSTRY MARKET, SHARE (%), BY DRUG TYPE, 2022
FIGURE 6 INDIA PHARMACEUTICALS INDUSTRY MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
FIGURE 7 CIPLA INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 8 CIPLA INC.: SWOT ANALYSIS
FIGURE 9 DR. REDDY’S LABORATORIES LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 10 DR. REDDY’S LABORATORIES LTD.: SWOT ANALYSIS
FIGURE 11 LUPIN LIMITED.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 12 LUPIN LIMITED.: SWOT ANALYSIS
FIGURE 13 UN PHARMACEUTICAL INDUSTRIES LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 UN PHARMACEUTICAL INDUSTRIES LTD.: SWOT ANALYSIS
FIGURE 15 CADILA PHARMACEUTICALS.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 CADILA PHARMACEUTICALS.: SWOT ANALYSIS
FIGURE 17 GLAXOSMITHKLINE PLC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 GLAXOSMITHKLINE PLC.: SWOT ANALYSIS
FIGURE 19 BIOCON LIMITED.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 BIOCON LIMITED.: SWOT ANALYSIS
FIGURE 21 PFIZER INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 PFIZER INC.: SWOT ANALYSIS
FIGURE 23 NOVARTIS AG.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 NOVARTIS AG.: SWOT ANALYSIS
FIGURE 25 MERCK & CO., INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 MERCK & CO., INC.: SWOT ANALYSIS
FIGURE 27 TORRENT PHARMA.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 TORRENT PHARMA.: SWOT ANALYSIS
FIGURE 29 DIVI'S LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 DIVI'S LABORATORIES: SWOT ANALYSIS
FIGURE 31 AUROBINDO PHARMA LIMITED: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 AUROBINDO PHARMA LIMITED: SWOT ANALYSIS
FIGURE 33 MANKIND PHARMA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 34 MANKIND PHARMA: SWOT ANALYSIS
FIGURE 35 ABBOTT: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 36 ABBOTT: SWOT ANALYSIS

Certified Researchers

Customize Report

India Pharmaceuticals Industry Research Report —Forecast till 2035 Segmentation

Market Segmentation Overview

Detailed segmentation data will be available in the full report
Comprehensive analysis by multiple parameters
Regional and country-level breakdowns
Market size forecasts by segment

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓

India Pharmaceuticals Industry

India Pharmaceuticals Industry Research Report —Forecast till 2035 Segmentation

Market Segmentation Overview

Related Reports

Customer Stories

Aerospace & Defense

Compare Licence